Forkhead Box Transcription Factors: Double-Edged Swords in Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35315926.
- Also identified by DOI 10.1158/0008-5472.CAN-21-3371 and PMC identifier 9258984.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead factors such as FOXA1 and FOXM1 are involved in hormone regulation, immune system modulation, and disease progression through their regulation of the epithelial-mesenchymal transition. Forkhead factors can influence cancer development, progression, metastasis, and drug resistance. In this review, we discuss the various roles of forkhead factors in biological processes that support cancer as well as their function as pioneering factors and their potential as targetable transcription factors in the fight against cancer.
Medical subject headings
- Drug Resistance, Neoplasm
- Forkhead Transcription Factors
- Neoplasms